Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
JoVE Journal
Immunology and Infection

This content is Open Access.

Multivirus特异性T细胞的生成,预防/治疗异基因造血干细胞移植后的病毒感染
 
Click here for the English version

Multivirus特异性T细胞的生成,预防/治疗异基因造血干细胞移植后的病毒感染

Article DOI: 10.3791/2736
May 27th, 2011

Chapters

Summary May 27th, 2011

Please note that all translations are automatically generated.

Click here for the English version.

一种快速,简便和成本效益的协议为代捐助衍生multivirus特异性CTL(rCTL)输注异体造血干细胞移植(HSCT)在发展巨细胞病毒,高级或EBV感染的风险收件人。这制造过程是按照GMP标准,并应确保实施专门的中心之外的更广泛的T细胞免疫。

Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter